Skip to main content

CITADEL ADVISORS LLC

Position in GTBP — GT Biopharma, Inc.

CIK 1423053 MIAMI, FL

Position in GTBP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$26,995
-$36,402 QoQ
Shares Held
66,165
-18.1% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Derivatives in GTBP

reported options exposure · as of Mar 31, 2023
CallValue
$0
CallShares
6,500
PutValue
$0
PutShares
1,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,531,283,955 across 373 Biotechnology names. GTBP ranks #340 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GTBP

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $26,995 66,165
2025-12-31 $63,397 80,761
2025-09-30 $23,264 39,633
2025-03-31 $43,296 20,138
2023-12-31 57,807
2023-03-31 1,000
2023-03-31 37,182
2023-03-31 6,500
2022-06-30 21,200
2022-06-30 60,977
2022-03-31 47,012
2022-03-31 25,800
2022-03-31 15,500
2021-12-31 50,300
2021-12-31 11,442
2021-12-31 17,800
2021-09-30 14,115
2021-09-30 64,200
2021-09-30 22,700
2021-06-30 510,058